期刊文献+

兔抗人CD1d分子α3结构域抗体的制备与鉴定 被引量:1

Preparation and characterization of the rabbit polyclonal antibody against the α3 domain of human CD1d
下载PDF
导出
摘要 目的:制备兔抗人CD1d分子α3结构域(hCD1d-α3)多克隆抗体。方法:PCR法扩增出人hCD1d-α3编码区基因,将其克隆入原核表达载体pET28中,转化大肠杆菌BL21(DE3),用IPTG诱导重组蛋白的表达,用Ni2+-NTA Agarose亲和层析法纯化重组蛋白,以之为免疫原免疫家兔,制备多克隆抗体,并用ELISA、Western blot及免疫组织化学法检测抗体。结果:成功构建了hCD1d-α3原核表达载体pET28/h CD1d-α3,高效表达并纯化hCD1d-α3蛋白,间接ELISA检测所制备抗体的效价为1∶6400,Western blot显示该抗体能与hCD1d特异结合,免疫组织化学法检测结果表明该抗体识别人小肠组织中的天然hCD1d。结论:通过制备重组hCD1d-α3蛋白为免疫原,免疫家兔,成功地制备了效价高、特异性好的抗hCD1d-α3多克隆抗体。 AIM:To prepare the rabbit antibody against the α3 domain of the human CD1d(hCD1d-α3).METHODS:The gene fragment coding for hCD1d-α3 was amplified by PCR and cloned into prokaryotic expression vector pET28,then expressed in E.coli BL21(DE3).The recombinant protein hCD1d-α3 was purified with Ni2+-NTA agarose column and used as immunogen to immunize the rabbit.The titer and specificity of the anti-hCD1d-α3 antibody from the rabbit were analyzed by ELISA,Western blot and immunohistochemistry,respectively.RESULTS...
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2008年第3期250-252,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 广东省中医药局科研基金资助项目(1060043)
关键词 CD1D α3结构域 表达 抗体 制备 CD1d α3 domain expression antibody preparation
  • 相关文献

参考文献10

  • 1[1]Borg NA,Wun KS,Kjer-Nielsen L,et al.CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor[J].Nature,2007,448(7149):44-49.
  • 2[2]Zimmer MI,Colmone A,Felio K,et al.A cell-type specific CD1d expression program modulates invariant NKT cell development and function[J].J Immunol,2006,176(3):1421-1430.
  • 3[3]Yang JQ,Wen X,Liu H,et al.Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model[J].Arthritis Rheum,2007,56(4):1219-1233.
  • 4[4]Haraguchi K,Takahashi T,Nakahara F,et al.CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells[J].Leuk Lymphoma,2006,47(10):2218-2223.
  • 5[5]Zajonc DM,Wilson IA.Architecture of CD1 proteins[J].Curr Top Microbiol Immunol,2007,314(1):27-50.
  • 6[6]Kojo S,Adachi Y,Tsutsumi A,et al.Alternative splicing forms of the human CD1d gene in mononuclear cells[J].Biochem Biophys Res Commun,2000,276(1):107-111.
  • 7陈章权,何素辉,陆田田,何天文,何韶衡.兔抗人肥大细胞羧肽酶抗体的制备与鉴定[J].细胞与分子免疫学杂志,2007,23(9):859-861. 被引量:10
  • 8[8]Dougan SK,Kaser A,Blumberg RS.CD1 expression on antigen-presenting cells[J].Curr Top Microbiol Immunol,2007,314(1):113-141.
  • 9[9]Blumberg RS.Characterization of CD1d in mucosal immune function:an immunotherapeutic target for inflammatory bowel disease[J].Keio J Med,2001,50(1):39-44.
  • 10[10]Paduraru C,Spiridon L,Yuan W.An N-linked glycan modulates the interaction between the CD1d heavy chain and beta 2-microglobulin[J].J Biol Chem,2006,281(52):40369-40378.

二级参考文献8

  • 1Payne V,Kam PC.Mast cell tryptase:A review of its physiology and clinical significance[J].Anaesthesia,2004,59(7):695-703.
  • 2Goldstein SM,Leong J,Schwartz LB,et al.Protease composition of excytosed human skin mast cell protease-proteoglycan complexes[J].J Immunol,1992,148(8):2475-2482.
  • 3Palczynski C,Walusiak J,Krakowiak A,et al.Nasal lavage fluid examination in diagnostics of occupational allergy to chloramine[J].Int J Occup Med Environ Health,2003,16(3):231-240.
  • 4Nishio H,Suzuki K.Serum tryptase levels in sudden infant death syndrome in forensic autopsy autopsy cases[J].Forensic Sci Int,2004,139(1):57-60.
  • 5Goldstein SM,Kaempfer CE,Kealey JT,et al.Human mast cell carboxypeptidase:Purification and characterization[J].J Clin Invest,1989,83(5):1630-1636.
  • 6Nallamsetty S,Austin BP,Penrose KJ,et al.Gateway vectors for the production of combinatorially tagged His6-MBP fusion proteins in the cytoplasm and periplasm of Escherichia coli[J].Protein Sci,2005,14(12):2964-2971.
  • 7Reynolds DS,Gurley DS,Austen KF,et al.Cloning and characterization of the novel gene for mast cell carboxypeptidase A[J].J Clin Invest,1992,89(1):273-282.
  • 8陈章权,何韶衡,陶爱林.人肥大细胞羧肽酶编码区基因的克隆与鉴定[J].细胞与分子免疫学杂志,2004,20(1):37-38. 被引量:3

共引文献9

同被引文献7

  • 1陈章权,何素辉,陆田田,何天文,何韶衡.兔抗人肥大细胞羧肽酶抗体的制备与鉴定[J].细胞与分子免疫学杂志,2007,23(9):859-861. 被引量:10
  • 2Zimmer MI, Colmone A, Felio K, et al. A cell-type specific CDld expression program modulates invariant NKT cell development and functlon[J]. J Immunol, 2006, 176(3) : 1421 - 1430.
  • 3Haraguchi K, Takahashi T, Nakahara F, et al. CDld expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells[J]. Leuk Lymphoma, 2006, 47(10) : 2218 - 2223.
  • 4Ilyinskii PO, Wang R, Balk SP, et al. CDld mediates T-cell-depend- ent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo [J]. J Virol, 2006, 80(14): 7146-7158.
  • 5Chen N, McCarthy C, Drakesmith H, et al. HIV-1 down-regulates the expression of CD1d via Nef[J]. Eur J Immunol, 2006, 36(2) : 278 - 286.
  • 6Fais F, Tenca C, Cimino G, et al. CDld expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis [ J ]. Leukemia, 2005, 19(4) : 551 -556.
  • 7Kojo S, Tsutsumi A, Goto D, et al. Low expression levels of soluble CDld gene in patients with rheumatoid arthritis [J]. J Rheumatol, 2003, 30(12) :2524 - 2528.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部